AA
RLMD icon

AlphaCentric Advisors’s Relmada Therapeutics RLMD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,500
Closed -$204K 208
2022
Q3
$204K Buy
+5,500
New +$204K 0.21% 105